The Hyperbolic NAMPT Inhibitor RPT1G Synergizes with BCL-2 Family Inhibitors and Helps Overcome Venetoclax Resistance in Acute Myeloid Leukemia Cells

被引：0
|
作者：
Crimmins, Gregory [1 ]
Wu, Min [1 ]
Roushar, Francis [1 ]
Aguilar, Claudia F. Ramos [1 ]
Gharghabi, Mehdi [2 ]
Cole, Banumathi [1 ]
Lapalombella, Rosa [2 ]
De Jesus-Diaz, Dennise A. [1 ]
机构：
[1] Remedy Plan Therapeut, Gaithersburg, MD USA
[2] Ohio State Univ, Columbus, OH USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-197972
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4134 / 4135
页数：2
相关论文
共 50 条
  • [1] RPT1G: A 1 st-in-Class Small Molecule NAMPT Inhibitor As a Novel Therapeutic for Acute Lymphocytic Leukemia
    Crimmins, Gregory
    Bhurruth-Alcor, Yushma
    Jarvela, Timothy
    Wu, Min
    Robb, Caroline M.
    Digel, James
    Moghaddam-Taaheri, Parisa
    De Jesus-Diaz, Dennise A.
    BLOOD, 2023, 142
  • [2] COMBINATORIAL BCL-2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX
    Waclawiczek, A.
    Leppa, A.
    Renders, S.
    Stumpf, K.
    Reyneri, C.
    Betz, B.
    Janssen, M.
    Shahswar, R.
    Donato, E.
    Unglaub, J. M.
    Schlenk, R. F.
    Hundemer, M.
    Pabst, C.
    Heuser, M.
    Raffel, S.
    Mueller-Tidow, C.
    Sauer, T. .
    Trumpp, A.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S45 - S45
  • [3] Effect and Mechanism of NL-101 Combined with Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia
    Jiang, Xia
    Zhuang, Haihui
    Li, Fenglin
    Jiang, Lei
    Jin, Jie
    Lu, Ying
    BLOOD, 2023, 142
  • [4] Tumor gene expression patterns affecting response to BCl-2 inhibitor venetoclax in acute myeloid leukemia
    Garay, Juan Antonio Raygoza
    Yun, Seongseok
    Osman, Afaf
    Ramlal, Reshma
    Feith, David
    Churchman, Michelle
    Dhakal, Prajwal
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
    Qi Zhang
    Bridget Riley-Gillis
    Lina Han
    Yannan Jia
    Alessia Lodi
    Haijiao Zhang
    Saravanan Ganesan
    Rongqing Pan
    Sergej N. Konoplev
    Shannon R. Sweeney
    Jeremy A. Ryan
    Yulia Jitkova
    Kenneth Dunner
    Shaun E. Grosskurth
    Priyanka Vijay
    Sujana Ghosh
    Charles Lu
    Wencai Ma
    Stephen Kurtz
    Vivian R. Ruvolo
    Helen Ma
    Connie C. Weng
    Cassandra L. Ramage
    Natalia Baran
    Ce Shi
    Tianyu Cai
    Richard Eric Davis
    Venkata L. Battula
    Yingchang Mi
    Jing Wang
    Courtney D. DiNardo
    Michael Andreeff
    Jeffery W. Tyner
    Aaron Schimmer
    Anthony Letai
    Rose Ann Padua
    Carlos E. Bueso-Ramos
    Stefano Tiziani
    Joel Leverson
    Relja Popovic
    Marina Konopleva
    Signal Transduction and Targeted Therapy, 7
  • [6] RAC1 Inhibitor EHT1864 and Venetoclax Overcome Midostaurin Resistance in Acute Myeloid Leukemia
    Garitano-Trojaola, Andoni
    Sancho, Ana
    Goetz, Ralph
    Walz, Susanne
    Jetani, Hardikkumar
    Teufel, Eva
    Rodhes, Nadine
    DaVia, Matteo
    Haertle, Larissa
    Nerreter, Silvia
    Vogt, Cornelia
    Duell, Johannes
    Tibes, Raoul
    Kraus, Sabrina
    Rosenwald, Andreas
    Rasche, Leo
    Hudecek, Michael
    Sauer, Markus
    Einsele, Hermann
    Groll, Juergen
    Kortuem, Martin
    BLOOD, 2019, 134
  • [7] AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia
    Legrand, Noemie
    Pradier, Amandine
    Poulain, Laury
    Mouche, Sarah
    Birsen, Rudy
    Larrue, Clement
    Simonetta, Federico
    Tamburini, Jerome
    CANCERS, 2021, 13 (23)
  • [8] A novel polyethylene glycol (PEG)-drug conjugate of Venetoclax, a Bcl-2 inhibitor, for treatment of acute myeloid leukemia (AML)
    Ando, Hidenori
    Murakami, Yuta
    Eshima, Kiyoshi
    Ishida, Tatsuhiro
    CANCER REPORTS, 2022, 5 (03)
  • [9] Strategies for the prophylaxis of invasive fungal diseases in acute myeloid leukemia patients undergoing Bcl-2 inhibitor venetoclax treatment
    Li, Pengfei
    Luo, Zhiming
    Deng, Jianchuan
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2025, 31 (02)
  • [10] Telomerase inhibitor imetelstat in combination with the BCL-2 inhibitor venetoclax enhances apoptosis in vitro and increases survival in vivo in acute myeloid leukemia
    Rusbuldt, Joshua J.
    Luistro, Leopoldo
    Chin, Diana
    Smith, Melissa
    Wong, Amy
    Romero, Margarita
    Rizo, Aleksandra
    Bussolari, Jacqueline
    Huang, Fei
    Sasser, Amy
    CANCER RESEARCH, 2017, 77
12345